Stabilizing the Boundary of the Fuzzy Volume of the Drug Use Structure——The Deep Meaning of the Volume Purchase of Guangdong Chemical Drugs

Following the renewal of contract 45 and 58 Chinese patent medicines, Guangdong’s largest volume of 153 chemical drugs and therapeutic biological products with the same generic name (that is, the same species) with large consumption and high purchase amount, the draft for comments on the procurement plan for the national day Finally surfaced the night before

In terms of participating provinces, as they belong to the chemical and biological medicine program, the alliance regions participating in the reporting of pharmaceuticals in this province include Guangdong, Shanxi, Jiangxi, Henan, Guangxi, Hainan, Guizhou, Qinghai, Ningxia, Xinjiang, Xinjiang Production and Construction Corps11 Provincial units

Speaking of the area of ​​mass procurement, here is a digression.

Back to the Guangdong program

It is worth mentioning that in the process of determining the product to be selected, the basic infusion introduces the 1.

On the whole, P1 basically locks in at least 70% of the stock as long as it confirms the lowest price in the country.

This point is clearly stated in the next plan to confirm the pre-purchasing volume: among the non-exclusive drugs, the first-year pre-purchasing volume of the first-year pre-purchased products of only the first-tier products to be selected in the A purchase order is the first in the alliance region.

Summarizing this Guangdong chemical medicine and biological medicine plan in general, the centralized procurement of chemical medicine in Guangdong Province actually does not have a clear limit on the number of eliminated companies, but only optimizes the market proportionally, that is, it will not rigidly eliminate a certain number of companies